Browse drugs

…ere achieved by 37/59 (62.7%) and 33/59 (55.9%) patients in the avacopan group and 34/57 (59.6%) and 30/57 (52.6%) in the prednisone tap…

…iven revascularisation, serious infection or diarrhoea. For the spironolactone comparison, the outcome included all-cause death, stroke, MI, n…

… duration of the analgesia was 636.4±212.4 minutes (mean±SD) in bupivacaine group when compared to 715.9±261.6 minutes in ropivacaine group…

…ral nerve, and TAP blocks. There have been some instances where bupivacaine used in a TAP block resulted in plasma concentrations above tox…

…red intervention (banding and/or sclerotherapy )before starting Carvedilol. Screening before commencing Carvedilol, dose of Carvedilol and…

… LV thrombus management, with comparable efficacy and safety to warfarin. Furthermore, our findings suggest more favourable clinical out…

… M, Green Z, Morris K. OC4 Discontinuation of premedication for infliximab infusions is well-tolerated, without adverse events, and cost-s…

… symptom control and lower therapy inadequacy risks compared to metoclopramide.Conclusions Ondansetron is superior to metoclopramide for preve…

…-23 signaling. Front. Immunol. 2025;16:1532852.Rubin DT, et al. Guselkumab in patients with moderately to severely active ulcerative colit…

…Introduction Risankizumab (RZB), a high-affinity humanised IgG1 monoclonal antibody targe…

… trial assessing nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in the first-line set…

…994, p=0.006), GDF-15 (1.194, p<0.001), U-PAR (0.630, p=0.008), CCL15 (0.938, p=0.015), PSP-D (1.106, p<0.001) and TNFSF13B (0.944, p…